INMED PHARMACEUTICALS INC (INM) Stock Balance Sheet
NASDAQ:INM - Nasdaq - CA4576377002 - Common Stock
| MRQ (2024-9-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 5.58M | 6.57M | 8.91M | 6.18M | 7.36M | |||
| Marketable Securities | 43.20K | 43.06K | 40.00K | 40.00K | 50.00K | |||
| Receivables | 284.70K | 352.84K | 260.00K | 90.00K | 10.00K | |||
| Inventories | 1.22M | 1.24M | 1.62M | 2.49M | N/A | |||
| Other Current Assets | 148.88K | 477.75K | 500.00K | 800.00K | 960.00K | |||
| Total Current Assets | 7.28M | 8.69M | 11.33M | 9.60M | 8.38M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.34M | 1.25M | 720.00K | 900.00K | 330.00K | |||
| Intangibles | 1.74M | 1.78M | 1.95M | 2.11M | 1.06M | |||
| Other Non-Current Assets | 100.00K | 100.00K | 100.00K | 180.00K | 10.00K | |||
| Total Non-Current Assets | 3.19M | 3.13M | 2.78M | 3.19M | 1.40M | |||
| TOTAL ASSETS | 10.47M | 11.82M | 14.11M | 12.79M | 9.78M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 80.00K | |||
| Accrued Expenses | 984.88K | 1.30M | 1.44M | 1.65M | 80.00K | |||
| Accounts Payable | 449.00K | 626.19K | 540.00K | 1.17M | 2.13M | |||
| Other Current Liabilities | 2.00K | 41.00K | 20.00K | 500.00K | N/A | |||
| Total Current Liabilities | 1.44M | 1.97M | 2.00M | 3.32M | 2.22M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 633.78K | 644.87K | 20.00K | 390.00K | 190.00K | |||
| Total Non-Current Liabilities | 633.78K | 644.86K | 20.00K | 390.00K | 180.00K | |||
| TOTAL LIABILITIES | 2.07M | 2.62M | 2.02M | 3.71M | 2.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -110.75M | -109.08M | -101.40M | -93.45M | -74.85M | |||
| Additional Paid In Capital | 34.82M | 35.37M | 35.74M | 31.68M | 21.51M | |||
| Common Shares | 84.20M | 82.78M | 77.62M | 70.72M | 60.59M | |||
| Other Shareholders' Equity | 128.57K | 128.57K | 130.00K | 130.00K | 130.00K | |||
| Shares Outstanding | 33.35K | 445.95K | 3.33M | 650.00K | 320.00K | |||
| Tangible Book Value per Share | 199.50 | 16.65 | 3.04 | 10.72 | 19.75 | |||
| Total Shareholders' Equity | 8.40M | 9.21M | 12.09M | 9.08M | 7.38M | |||
| TOTAL LIABILITIES AND EQUITY | 10.47M | 11.82M | 14.11M | 12.79M | 9.78M | |||
| Statistics | ||||||||
| Current Ratio | 5.07 | 4.41 | 5.67 | 2.89 | 3.77 | |||
| Return On Assets (ROA) | -65.14% | -64.92% | -56.34% | -145.43% | -104.29% | |||
| Return On Equity (ROE) | -81.19% | -83.37% | -65.76% | -204.85% | -138.21% | |||
All data in USD , ROIC based on taxRate of 0.21